Translate
Zealand Pharma A/s
About
310.60DKK-25.40 -7.56%
Closed • Updated at 02:58 GMT+00:00Market Cap$3.44B
P/E Ratio3.49
Volume679.9K
Beta0.90
RSI48.48
Gross Margin99.66%
Zealand Pharma A/s — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Zealand Pharma Announces Financial Results for the First Three Months of 2026
May 7 2026
Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program
May 1 2026
Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026
Apr 30 2026
Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results
Apr 29 2026
Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management
Recent Videos
Zealand Pharma #001
Jan 10, 2026
Zealand Pharma Stock Analysis
Mar 13, 2025
Fireside Chat with David Kendall, Zealand Pharma and Jay Olson, Oppenheimer & Co. Inc. @ Sachs_BOIF
Jan 31, 2025
Aktionærens Julekalender | 23. Zealand Pharma
Dec 23, 2024